Hosted on MSN11m
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
Medtronic MDT came up with a mixed performance for the third quarter of fiscal 2025, sparking investor concerns and a ...
medtechdive35m
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.